RE: Nursing home equipment to track COVID15 Nov 2021 04:17
I recall that the MW takeover received criticism from some quarters at the time due to the " good deal" that it was for MW, given that we already had a contractual arrangement on the reagents/AI.
However, the potential value that PD, and MW as a whole, could unlock is astronomical. If we only had the reagent/AI slice of that pie we would probably be ruing the fact a takeover never happened.
Looking back, the decision to acquire MW when we did looks to be a masterstroke. Some will point to GB, as a substantial MW shareholder, feathering his own nest but if the merger creates significant value for ALL shareholders then who could criticise the man that has the vision for all this in the first place? I certainly didn't/don't.
Having said that, i don't want us going in for MSYS at this time. The micro mass spectrometers look interesting, but i would rather retain our contractual ties with them for now. It could be advantageous to take them over one day, but given that it would likely be a share for share deal (a la MW) i would like DVRG to be worth a lot more before doing so, to limit the effective dilution. If DVRG were worth, say, £300m mcap then acquiring MSYS for, say, £30m with a share for share agreement is only 10% dilution.
At this moment in time MSYS brings a lot less to the DVRG party than MW did at the time. So far we have all received our invites and i can't wait for the party to start. Who knows, it could be sooner than we all think.
The world needs DVRG. We are lining up the ability to give it to them
Sign In
Follow the stocks
